A PROSPECTIVE STUDY ON DRUG UTILISATION AND EVALUATION OF ANTI-RETROVIRAL THERAPY AND ANTI-TUBERCULOSIS TREATMENT IN A TERTIARY CARE HOSPITAL

SUHAIL, SHAIK MOHAMMED and KANDIPALLI, DIVYA and LAKSHMI, . and KUMAR, ASHOK C. and REDDY, M. VENU MADHAV and LAKSHMI, M. PRAHARSHA and CHANDRA, P. SAMUEL (2022) A PROSPECTIVE STUDY ON DRUG UTILISATION AND EVALUATION OF ANTI-RETROVIRAL THERAPY AND ANTI-TUBERCULOSIS TREATMENT IN A TERTIARY CARE HOSPITAL. Journal of Disease and Global Health, 15 (1). pp. 9-17. ISSN 2454-1842

Full text not available from this repository.

Abstract

Acquired immune deficiency syndrome is the most serious consequence of infection due to HIV which is a major health problem in public. India is with one sixth of world’s population where one of every eight people is HIV infected. Worldwide, tuberculosis is the common serious infection in HIV infected people. WHO estimated that 13% of 8.7 million individuals who develop incidence tuberculosis are co-infected with HIV. The research followed Prospective Observational Study of Anti-retroviral drugs and Anti-tubercular drugs. The total number of drugs for HIV and TB, were collected from inpatient records, as per the prescription, dose, and route of administration. The study involves the above 18 years old patients and it is planned over 6 months of period in ART CENTER. The demographic data and patient characteristics affected with HIV/AIDS and TB group were enrolled in the study. The analysis of study includes, a total number of 220 prescriptions during the research involving 152 males and 52 females and 16 other patients. The drug utility and evaluation for HIV and TB patients were with ART and ATT and with other poly-pharmacy to improve the immune system that is most important in HIV and TB.

Item Type: Article
Subjects: STM Academic > Medical Science
Depositing User: Unnamed user with email support@stmacademic.com
Date Deposited: 25 Nov 2023 08:12
Last Modified: 25 Nov 2023 08:12
URI: http://article.researchpromo.com/id/eprint/1829

Actions (login required)

View Item
View Item